# PeptideScanner evidence objects: Petrelintide

Every published version of the records placed with Petrelintide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/petrelintide.json. Selected public evidence only; not medical advice.

- Objects: 13
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct06662539-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT06662539

> PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct06662539-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06662539-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct06662539-petrelintide-v1
- Content SHA-256: `9d18eacf08df0e4904b5edae91b00ce77cdf45d742ec869688069647effc90da`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06662539 ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

### Sources

<a id="source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb"></a>
- **ClinicalTrials.gov record NCT06662539 · retained source version 2026-03-23:25a9d8533efb66766440e5abf5b03342f70235dae33ae71a773e757bb8847402** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06662539) (`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06662539." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct06662539-petrelintide-v1 SHA-256: 9d18eacf08df0e4904b5edae91b00ce77cdf45d742ec869688069647effc90da.

---

<a id="clinicaltrials-gov-nct06926842-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT06926842

> PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct06926842-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-09-09
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06926842-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct06926842-petrelintide-v1
- Content SHA-256: `3c37f8c982416ff97a11815e982272c9d857ae1e543bdc173fb65a0317b9f858`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06926842 ([`ctg-observation-nct06926842-2026-09-09-66566db76c0b`](#source-ctg-observation-nct06926842-2026-09-09-66566db76c0b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06926842-2026-09-09-66566db76c0b`](#source-ctg-observation-nct06926842-2026-09-09-66566db76c0b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06926842-2026-09-09-66566db76c0b`](#source-ctg-observation-nct06926842-2026-09-09-66566db76c0b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06926842-2026-09-09-66566db76c0b`](#source-ctg-observation-nct06926842-2026-09-09-66566db76c0b))

### Sources

<a id="source-ctg-observation-nct06926842-2026-09-09-66566db76c0b"></a>
- **ClinicalTrials.gov record NCT06926842 · retained source version 2026-09-09:66566db76c0ba35707f571957d43a26bb1a34c1cb277263d2109ca1fdebaf137** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06926842) (`ctg-observation-nct06926842-2026-09-09-66566db76c0b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06926842." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct06926842-petrelintide-v1 SHA-256: 3c37f8c982416ff97a11815e982272c9d857ae1e543bdc173fb65a0317b9f858.

---

<a id="clinicaltrials-gov-nct07076030-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07076030

> PeptideScanner retained ClinicalTrials.gov record NCT07076030 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07076030-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07076030-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07076030-petrelintide-v1
- Content SHA-256: `44881e980e657c089ae8fecaa8fff3104f9ebb9a875ae7a59e5aa642b0994eb8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07076030 ([`ctg-observation-nct07076030-2026-01-28-68a10be352b4`](#source-ctg-observation-nct07076030-2026-01-28-68a10be352b4))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07076030 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07076030-2026-01-28-68a10be352b4`](#source-ctg-observation-nct07076030-2026-01-28-68a10be352b4))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07076030 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07076030-2026-01-28-68a10be352b4`](#source-ctg-observation-nct07076030-2026-01-28-68a10be352b4))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07076030-2026-01-28-68a10be352b4`](#source-ctg-observation-nct07076030-2026-01-28-68a10be352b4))

### Sources

<a id="source-ctg-observation-nct07076030-2026-01-28-68a10be352b4"></a>
- **ClinicalTrials.gov record NCT07076030 · retained source version 2026-01-28:68a10be352b494ee43c532b4782a5eda7e3dc609ba1c5da1829378a353712497** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07076030) (`ctg-observation-nct07076030-2026-01-28-68a10be352b4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07076030." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07076030-petrelintide-v1 SHA-256: 44881e980e657c089ae8fecaa8fff3104f9ebb9a875ae7a59e5aa642b0994eb8.

---

<a id="clinicaltrials-gov-nct07338214-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07338214

> PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07338214-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07338214-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07338214-petrelintide-v1
- Content SHA-256: `0c89e8527f877a86543ea4d3bc21aeb244015f377720754f859cc67d2af5ca17`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07338214 ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

### Sources

<a id="source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d"></a>
- **ClinicalTrials.gov record NCT07338214 · retained source version 2026-04-08:ee70b78b750de2d906d9b43983d8d05515168ccdc89ef2bf4a818f4b0a007791** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07338214) (`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07338214." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07338214-petrelintide-v1 SHA-256: 0c89e8527f877a86543ea4d3bc21aeb244015f377720754f859cc67d2af5ca17.

---

<a id="clinicaltrials-gov-nct07589686-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07589686

> PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07589686-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-07
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07589686-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07589686-petrelintide-v1
- Content SHA-256: `e735ceec6582134c50f05f32b90774042017987f8b4e3f935926b3f4e1f1b5a8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07589686 ([`ctg-observation-nct07589686-2026-08-07-57ec1de966dc`](#source-ctg-observation-nct07589686-2026-08-07-57ec1de966dc))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07589686-2026-08-07-57ec1de966dc`](#source-ctg-observation-nct07589686-2026-08-07-57ec1de966dc))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07589686-2026-08-07-57ec1de966dc`](#source-ctg-observation-nct07589686-2026-08-07-57ec1de966dc))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07589686-2026-08-07-57ec1de966dc`](#source-ctg-observation-nct07589686-2026-08-07-57ec1de966dc))

### Sources

<a id="source-ctg-observation-nct07589686-2026-08-07-57ec1de966dc"></a>
- **ClinicalTrials.gov record NCT07589686 · retained source version 2026-08-07:57ec1de966dc2356b5a5ba336b4b04168bc3acba53fe3e5ccfc51e0255d655e0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07589686) (`ctg-observation-nct07589686-2026-08-07-57ec1de966dc`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07589686." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07589686-petrelintide-v1 SHA-256: e735ceec6582134c50f05f32b90774042017987f8b4e3f935926b3f4e1f1b5a8.

---

<a id="clinicaltrials-gov-nct07682818-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07682818

> PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07682818-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07682818-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07682818-petrelintide-v1
- Content SHA-256: `53e2cef57c890c83e85cece7945d0a0de1c5ea4ca4acfc82a22c257cca398531`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07682818 ([`ctg-observation-nct07682818-2026-07-06-331a37942691`](#source-ctg-observation-nct07682818-2026-07-06-331a37942691))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07682818-2026-07-06-331a37942691`](#source-ctg-observation-nct07682818-2026-07-06-331a37942691))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07682818-2026-07-06-331a37942691`](#source-ctg-observation-nct07682818-2026-07-06-331a37942691))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07682818-2026-07-06-331a37942691`](#source-ctg-observation-nct07682818-2026-07-06-331a37942691))

### Sources

<a id="source-ctg-observation-nct07682818-2026-07-06-331a37942691"></a>
- **ClinicalTrials.gov record NCT07682818 · retained source version 2026-07-06:331a37942691799546f51e2f309eb4d5ff605dfac8553a80c18224b6f4580699** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07682818) (`ctg-observation-nct07682818-2026-07-06-331a37942691`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07682818." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07682818-petrelintide-v1 SHA-256: 53e2cef57c890c83e85cece7945d0a0de1c5ea4ca4acfc82a22c257cca398531.

---

<a id="clinicaltrials-gov-nct07843472-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07843472

> PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07843472-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-07
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07843472-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843472-petrelintide-v1
- Content SHA-256: `e832a7d6db23eb590ce3fbc9c476c54064f1ab424030534f50bd646dfe40a2d8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07843472 ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b))

### Sources

<a id="source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b"></a>
- **ClinicalTrials.gov record NCT07843472 · retained source version 2026-10-07:b4d7f3eecf4b6c9a8842198319f5d5c3a421bf03ca09434d4d315fdacfc97697** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07843472) (`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07843472." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843472-petrelintide-v1 SHA-256: e832a7d6db23eb590ce3fbc9c476c54064f1ab424030534f50bd646dfe40a2d8.

---

<a id="clinicaltrials-gov-nct07843472-petrelintide-v2"></a>

## ClinicalTrials.gov record NCT07843472

> PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07843472-petrelintide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07843472-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843472-petrelintide-v2
- Content SHA-256: `cd6787343cde8d7ac7d1d637a5c80437f7d450c744bfda6b0d25a4c7be4cc50f`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07843472 ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2))

### Sources

<a id="source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2"></a>
- **ClinicalTrials.gov record NCT07843472 · retained source version 2026-11-16:badab750128a1703566522fa63aad6d06cef78727a09290afc35bbac50cad975** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07843472) (`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`)

### Correction lineage

updated on 2026-11-16: ClinicalTrials.gov posted a newer version of NCT07843472, with a registry update date of 2026-11-16. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2`](#source-ctg-observation-nct07843472-2026-10-07-b4d7f3eecf4b-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07843472." Version 2, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843472-petrelintide-v2 SHA-256: cd6787343cde8d7ac7d1d637a5c80437f7d450c744bfda6b0d25a4c7be4cc50f.

---

<a id="clinicaltrials-gov-nct07843485-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07843485

> PeptideScanner retained ClinicalTrials.gov record NCT07843485 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07843485-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-05
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07843485-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843485-petrelintide-v1
- Content SHA-256: `bae1c9f20d9a0ece470041b4cfb289254e9a6b5cc0d6466632130d3fd7a5f0f0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07843485 ([`ctg-observation-nct07843485-2026-11-05-e5fd0540362d`](#source-ctg-observation-nct07843485-2026-11-05-e5fd0540362d))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07843485 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843485-2026-11-05-e5fd0540362d`](#source-ctg-observation-nct07843485-2026-11-05-e5fd0540362d))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07843485 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843485-2026-11-05-e5fd0540362d`](#source-ctg-observation-nct07843485-2026-11-05-e5fd0540362d))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07843485-2026-11-05-e5fd0540362d`](#source-ctg-observation-nct07843485-2026-11-05-e5fd0540362d))

### Sources

<a id="source-ctg-observation-nct07843485-2026-11-05-e5fd0540362d"></a>
- **ClinicalTrials.gov record NCT07843485 · retained source version 2026-11-05:e5fd0540362d59efc4e0e476ab3f05c74427735d5576cee67cbafed4c6f394d5** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07843485) (`ctg-observation-nct07843485-2026-11-05-e5fd0540362d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07843485." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843485-petrelintide-v1 SHA-256: bae1c9f20d9a0ece470041b4cfb289254e9a6b5cc0d6466632130d3fd7a5f0f0.

---

<a id="clinicaltrials-gov-nct07843498-petrelintide-v1"></a>

## ClinicalTrials.gov record NCT07843498

> PeptideScanner retained ClinicalTrials.gov record NCT07843498 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07843498-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-05
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07843498-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843498-petrelintide-v1
- Content SHA-256: `d5b75edd14e45fdaa1e9a211c537514644bfa5869b68f424571d3824de469773`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07843498 ([`ctg-observation-nct07843498-2026-11-05-9b532d149aaf`](#source-ctg-observation-nct07843498-2026-11-05-9b532d149aaf))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07843498 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843498-2026-11-05-9b532d149aaf`](#source-ctg-observation-nct07843498-2026-11-05-9b532d149aaf))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07843498 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07843498-2026-11-05-9b532d149aaf`](#source-ctg-observation-nct07843498-2026-11-05-9b532d149aaf))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07843498-2026-11-05-9b532d149aaf`](#source-ctg-observation-nct07843498-2026-11-05-9b532d149aaf))

### Sources

<a id="source-ctg-observation-nct07843498-2026-11-05-9b532d149aaf"></a>
- **ClinicalTrials.gov record NCT07843498 · retained source version 2026-11-05:9b532d149aaffed6b38bd85ef1731c2342003d62a19554586ffc692016cb1e62** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07843498) (`ctg-observation-nct07843498-2026-11-05-9b532d149aaf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07843498." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#clinicaltrials-gov-nct07843498-petrelintide-v1 SHA-256: d5b75edd14e45fdaa1e9a211c537514644bfa5869b68f424571d3824de469773.

---

<a id="petrelintide-combination-study-posted-v1"></a>

## Petrelintide combination study record posted

> ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche.

- Evidence object: `story:petrelintide-combination-study-posted:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-07
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/petrelintide-combination-study-posted/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#petrelintide-combination-study-posted-v1
- Content SHA-256: `39724849c6e05ddf3082af81a635610f29f857d0c51c9c4beccb64ba93982805`

### Claims and source pins

#### Headline

Petrelintide combination study record posted ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

#### Summary

ClinicalTrials.gov lists a Petrelintide study that is not yet recruiting sponsored by Hoffmann-La Roche. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

#### Paragraph 1

ClinicalTrials.gov lists the NCT07589686 record under Hoffmann-La Roche. Its overall recruitment status was shown as not yet recruiting when PeptideScanner reviewed the record. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

#### Paragraph 2

The registry shows 2026-07-07 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct07589686-v3`](#source-ctg-nct07589686-v3))

### Sources

<a id="source-ctg-nct07589686-v3"></a>
- **Petrelintide With Enicepatide in Adults With Obesity or Overweight · record history version 3 · last update posted 2026-07-07** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07589686?a=3&tab=history) (`ctg-nct07589686-v3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Petrelintide combination study record posted." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#petrelintide-combination-study-posted-v1 SHA-256: 39724849c6e05ddf3082af81a635610f29f857d0c51c9c4beccb64ba93982805.

---

<a id="pubmed-pmid-42017294-petrelintide-v1"></a>

## PubMed record PMID 42017294

> PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42017294-petrelintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42017294-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#pubmed-pmid-42017294-petrelintide-v1
- Content SHA-256: `3f0425ed8576602dc66137099cf009a5e0d27f7e5df0bb2ce30f3abb2581e661`

### Claims and source pins

#### Headline

PubMed record PMID 42017294 ([`pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8`](#source-pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8`](#source-pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8`](#source-pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8`](#source-pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8))

### Sources

<a id="source-pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8"></a>
- **PubMed record PMID 42017294 · retained source version 1:2026-07-26:current:4f621ecf45e8b6bc3e9a3890cad3f17fbebf071d9b11acecf3af8ba1bc7ca2a7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42017294/) (`pubmed-observation-pmid-42017294-2026-07-26-4f621ecf45e8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42017294." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#pubmed-pmid-42017294-petrelintide-v1 SHA-256: 3f0425ed8576602dc66137099cf009a5e0d27f7e5df0bb2ce30f3abb2581e661.

---

<a id="pubmed-pmid-42810353-petrelintide-v1"></a>

## Petrelintide and the evolving role of amylin agonism in obesity.

> PubMed lists PMID 42810353 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2026-09-29 (day precision). PeptideScanner associated the retained record with the identity slug petrelintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42810353-petrelintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-13
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42810353-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#pubmed-pmid-42810353-petrelintide-v1
- Content SHA-256: `9281b0df7bcac7e665a41d030e39c2e0b53f0543a9d711f370ce25944e2edd14`

### Claims and source pins

#### Headline

Petrelintide and the evolving role of amylin agonism in obesity. ([`pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf`](#source-pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf))

#### Summary

PubMed lists PMID 42810353 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2026-09-29 (day precision). PeptideScanner associated the retained record with the identity slug petrelintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf`](#source-pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf))

#### Paragraph 1

PubMed lists PMID 42810353 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2026-09-29 (day precision). PeptideScanner associated the retained record with the identity slug petrelintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf`](#source-pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf`](#source-pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf))

### Sources

<a id="source-pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf"></a>
- **Petrelintide and the evolving role of amylin agonism in obesity. · retained source version 1:2026-10-13:current:4197fa94ebcfd9d2f4f0875be362a9535f6d7ba099aad77c52e42f0398db1502** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42810353/) (`pubmed-observation-pmid-42810353-2026-10-13-4197fa94ebcf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Petrelintide and the evolving role of amylin agonism in obesity." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/petrelintide.json#pubmed-pmid-42810353-petrelintide-v1 SHA-256: 9281b0df7bcac7e665a41d030e39c2e0b53f0543a9d711f370ce25944e2edd14.

